Exploration of different statistical approaches in the comparison of dopamine and norepinephrine in the treatment of shock: SOAP II.

Fernando G ZampieriSean M BagshawHassane NjimiJean-Louis VincentDaniel De Backernull null

Published in: Critical care (London, England) (2024)

The harm associated with the use of dopamine for the management of shock appears to be present in both septic and cardiogenic shock patients. There was no suggestion of any subgroup in which dopamine was found to be favourable over norepinephrine.

Keyphrases

uric acid
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
acute kidney injury
prefrontal cortex
metabolic syndrome
patient reported outcomes
clinical trial
smoking cessation
clinical evaluation